Clinical Research Directory
Browse clinical research sites, groups, and studies.
Critical Illness After Hematopoietic Cell Transplantation
Sponsor: Peking University People's Hospital
Summary
This is a prospective, multicenter observational trial for patients who develop critical illness after hematopoietic cell transplantation. Patients who are admitted to the intensive care unit after undergoing hematopoietic cell transplantation at the participating medical centers will be enrolled in this study. The clinical characteristics, laboratory profiles, managements, and clinical outcomes will be prospectively collected.
Official title: Critical Illness Among Recipients of Hematopoietic Cell Transplantation (CARE-HCT): a Prospective, Multicenter Observational Study in China
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
4000
Start Date
2026-01-01
Completion Date
2036-12-31
Last Updated
2026-01-09
Healthy Volunteers
No
Conditions
Locations (6)
Peking University People's Hospital
Beijing, China
Xinqiao hospital of the third military medical university
Chongqing, China
First Affiliated Hospital of Zhejiang University
Hangzhou, China
First Affiliated Hospital of Harbin Medical University
Harbin, China
Hematology Hospital of Chinese Academy of Medical Sciences
Tianjin, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China